Hosted on MSN4d
Profits fall by 27% at Abbvie's Botox plant at WestportUse precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...
Irish Independent on MSN3d
Profits drop at Botox plant in Westport as revenues down by 4pcPre-tax profits at AbbVie’s global production facility for Botox, in Westport, last year declined by 27pc to $1.1bn (€1.04bn) ...
The U.S. Food and Drug Administration (FDA) has approved the fourth indication for AbbVie's (NYSE:ABBV) anti-wrinkle therapy Botox Cosmetic, expanding its use beyond the face for the first time ...
A strand of Merz Pharmaceuticals’ star-studded promotion of the anti-wrinkle drug Xeomin has landed it a reprimand from the ...
Last year, pharmaceutical giant AbbVie (NYSE: ABBV) lost patent exclusivity for its biggest cash cow, immunology medicine ...
Shares in AbbVie slumped Monday after the company disclosed its psychiatric medicine emraclidine didn’t best placebo in two ...
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced that the sixth annual BOTOX® Cosmetic Day will be Wednesday, ...
We know from history that the aesthetic version of masculine is hard, angular, and intrusive. And now it can be created by ...
(AbbVie) To enter the contest ... That trio of treatments consists of Qulipta, Botox and Ubrelvy. According to a recent analysis from GlobalData, the last of these is expected to be the top ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback